Details for Patent: 6,579,865
✉ Email this page to a colleague
Summary for Patent: 6,579,865
Title: | Penetration enhancing and irritation reducing systems |
Abstract: | This invention lies in the technology of transdermal and topical drug delivery. In particular, the present invention relates to enhancement of the penetration of transdermally or topically applied drugs and with the reduction of skin irritation that often accompanies transdermal and topical drug delivery. |
Inventor(s): | Mak; Vivien H. W. (Menlo Park, CA), Grayson; Stephen (San Rafael, CA) |
Assignee: | Cellegy Pharmaceuticals, Inc. (So. San Francisco, CA) |
Application Number: | 09/963,287 |
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 6,579,865
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,579,865
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 418988 | ⤷ Try a Trial | |||
Australia | 1313299 | ⤷ Try a Trial | |||
Australia | 747041 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |